Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

427
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
427
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

541
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
541

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The contribution of rare germline variants to the immune landscape of breast cancer.

Genome medicine·2026
Same author

Long-term outcomes of surgical menopause after risk-reducing salpingo-oophorectomy: results of the HARMOny study.

Maturitas·2026
Same author

Later age of natural menopause among women with the pathogenic <i>CHEK2</i> c.1100delC variant: a validation study.

Journal of medical genetics·2026
Same author

Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapy.

Breast cancer research and treatment·2026
Same author

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

Breast (Edinburgh, Scotland)·2025
Same author

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

NPJ genomic medicine·2025

Related Experiment Video

Updated: May 2, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

11.6K

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.

Inge-Marie Obdeijn1, Gonneke A O Winter-Warnars, Ritse M Mann

  • 1Department of Radiology, Erasmus University Medical Center Rotterdam, Groene Hilledijk 301, 3075, EA, Rotterdam, The Netherlands, a.obdeijn@erasmusmc.nl.

Breast Cancer Research and Treatment
|February 26, 2014
PubMed
Summary

Digital mammography offers minimal added value for breast cancer screening in BRCA1 mutation carriers. MRI is more sensitive, and mammography may be deferred until age 40 to reduce radiation exposure.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

16.2K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.0K

Related Experiment Videos

Last Updated: May 2, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

11.6K
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

16.2K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.0K

Area of Science:

  • Oncology
  • Radiology
  • Genetics

Background:

  • BRCA1 mutation carriers undergo regular screening using MRI and mammography.
  • The added benefit of digital mammography alongside MRI in this high-risk group requires evaluation.

Purpose of the Study:

  • To assess the incremental value of digital mammography compared to MRI for breast cancer detection in BRCA1 mutation carriers.
  • To determine optimal screening strategies considering cancer detection rates and potential radiation risks.

Main Methods:

  • Retrospective review of screening images and reports for BRCA1 carriers diagnosed with breast cancer between 2003 and 2013.
  • Assessment of screen-detection versus interval cancers and visibility on mammography and MRI using BI-RADS classification.

Main Results:

  • MRI detected 93.6% of cancers, while mammography detected 51.1%.
  • MRI alone identified 44.7% of malignancies; mammography alone identified 2.1% (DCIS).
  • Digital mammography added only 2% to overall cancer detection; no benefit observed in women under 40.

Conclusions:

  • MRI is the primary effective screening tool for BRCA1 mutation carriers.
  • Mammographic screening may be delayed until age 40 to mitigate radiation risks in younger carriers.
  • Yearly MRI screening from age 25 is recommended for BRCA1 carriers.